Macrophages as biomarkers in BCG treatment response in bladder cancer

Bladder cancer is a common urologic cancer and the majority has origin in the urothelium. Patients with intermediate and high risk of recurrence/progression bladder cancer are treated with intravesical instillation with Bacillus Calmette-Guérin, however, approximately 30% of patients do not respond to treatment. At the moment, there are no accepted biomarkers do predict treatment outcome and an early identification of patients better served by alternative therapeutics. The treatment initiates a cascade of cytokines responsible by recruiting macrophages to the tumor site that have been shown to influence treatment outcome. Effective BCG therapy needs precise activation of the Th1 immune pathway associated with M1 polarized macrophages. However, tumor-associated macrophages (TAMs) often assume an immunoregulatory M2 phenotype, either immunosuppressive or angiogenic, that interfere in different ways with the BCG induced antitumor immune response. The M2 macrophage is influenced by different microenvironments in the stroma and the tumor. In particular, the degree of hypoxia in the tumors is responsible by the recruitment and differentiation of macrophages into the M2 angiogenic phenotype, suggested to be associated with the response to treatment. Nevertheless, neither the macrophage phenotypes present nor the influence of localization and hypoxia have been addressed in previous studies. Therefore, this work devoted to study the influence of TAMs, in particular of the M2 phenotype taking into account their localization (stroma or tumor) and the degree of hypoxia in the tumor (low or high) in BCG treatment outcome. The study included 99 bladder cancer patients treated with BCG. Tumors resected prior to treatment were evaluated using immunohistochemistry for CD68 and CD163 antigens, which identify a lineage macrophage marker and a M2-polarized specific cell surface receptor, respectively. Tumor hypoxia was evaluated based on HIF-1α expression. As a main finding it was observed that a high predominance of CD163+ macrophage counts in the stroma of tumors under low hypoxia was associated with BCG immunotherapy failure, possibly due to its immunosuppressive phenotype. This study further reinforces the importance the tumor microenvironment in the modulation of BCG responses.

Redes Neuronais Artificiais na Otimização do Processo de Digestão Anaeróbia - Aplicação a uma ETAR da AdCL

Numa sociedade com elevado consumo energético, a dependência de combustíveis fósseis em evidente diminuição de disponibilidades é um tema cada vez mais preocupante, assim como a poluição atmosférica resultante da sua utilização. Existe, portanto, uma necessidade crescente de recorrer a energias renováveis e promover a otimização e utilização de recursos. A digestão anaeróbia (DA) de lamas é um processo de estabilização de lamas utilizado nas Estações de Tratamento de Águas Residuais (ETAR) e tem, como produtos finais, a lama digerida e o biogás. Maioritariamente constituído por gás metano, o biogás pode ser utilizado como fonte de energia, reduzindo, deste modo, a dependência energética da ETAR e a emissão de gases com efeito de estufa para a atmosfera. A otimização do processo de DA das lamas é essencial para o aumento da produção de biogás. No presente relatório de estágio, as Redes Neuronais Artificiais (RNA) foram aplicadas ao processo de DA de lamas de ETAR. As RNA são modelos simplificados inspirados no funcionamento das células neuronais humanas e que adquirem conhecimento através da experiência. Quando a RNA é criada e treinada, produz valores de output aproximadamente corretos para os inputs fornecidos. Uma vez que as DA são um processo bastante complexo, a sua otimização apresenta diversas dificuldades. Foi esse o motivo para recorrer a RNA na otimização da produção de biogás nos digestores das ETAR de Espinho e de Ílhavo da AdCL, utilizando o software NeuralToolsTM da PalisadeTM, contribuindo, desta forma, para a compreensão do processo e do impacto de algumas variáveis na produção de biogás.

Artificial antibodies for troponin T by its imprinting on the surface of multiwalled carbon nanotubes: Its use as sensory surfaces

A novel artificial antibody for troponin T (TnT) was synthesized by molecular imprint (MI) on the surface of multiwalled carbon nanotubes (MWCNT). This was done by attaching TnT to the MWCNT surface, and filling the vacant spaces by polymerizing under mild conditions acrylamide (monomer) in N,N′-methylenebisacrylamide (cross-linker) and ammonium persulphate (initiator). After removing the template, the obtained biomaterial was able to rebind TnT and discriminate it among other interfering species. Stereochemical recognition of TnT was confirmed by the non-rebinding ability displayed by non-imprinted (NI) materials, obtained by imprinting without a template. SEM and FTIR analysis confirmed the surface modification of the MWCNT. The ability of this biomaterial to rebind TnT was confirmed by including it as electroactive compound in a PVC/plasticizer mixture coating a wire of silver, gold or titanium. Anionic slopes of 50 mV decade−1 were obtained for the gold wire coated with MI-based membranes dipped in HEPES buffer of pH 7. The limit of detection was 0.16 μg mL−1. Neither the NI-MWCNT nor the MWCNT showed the ability to recognize the template. Good selectivity was observed against creatinine, sucrose, fructose, myoglobin, sodium glutamate, thiamine and urea. The sensor was tested successfully on serum samples. It is expected that this work opens new horizons on the design of new artificial antibodies for complex protein structures.